FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns new modes of use of preparations for liver treatment based on placenta hydrolysate. Use of Laennek is disclosed in method of treating liver cirrhosis, characterized by the fact that patient gets 10.0 ml intravenous drop introduction of preparation Laennek, dissolved in 250 ml of saline solution (0.9 % sodium chloride solution) or 5 % glucose solution during 1 hour 30 minutes, 2 times a week for 3 months.
EFFECT: method provides effective treatment of cirrhosis of various aetiologies.
3 cl, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ACUTE HEPATITIS B OR C WITH SEVERE CLINICAL COURSE | 2015 |
|
RU2599037C1 |
| METHOD OF TREATING AND PREVENTING AGE-ASSOCIATED DISEASES | 2018 |
|
RU2709488C1 |
| INTRAVENOUS DROPLET COMPOSITION BASED ON PURIFIED PLACENTA HYDROLYSATE (VERSIONS) | 2007 |
|
RU2356561C1 |
| METHOD FOR TREATING THE CASES OF CHRONIC DIFFUSE HEPATIC DISEASES | 2004 |
|
RU2283113C2 |
| METHOD FOR PREDICTING THE PROGRESSION OF VIRAL LIVER CIRRHOSIS | 2021 |
|
RU2784344C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS | 2003 |
|
RU2243784C2 |
| METHOD OF TREATING PATIENTS WITH HEPATIC CIRRHOSIS | 2012 |
|
RU2509566C1 |
| METHOD FOR TREATING HEPATIC CIRRHOSIS | 2000 |
|
RU2165775C1 |
| USE OF PREPARATION LAENNEK FOR TREATING A DISEASE, ASSOCIATED WITH IMPAIRED IMMUNITY, WHICH IS A CHRONIC RECURRENT HERPES, ATOPIC DERMATITIS OR PSORIASIS | 2015 |
|
RU2599038C1 |
| APPLICATION OF PREPARATION LAENNEK FOR REDUCTION OR ELIMINATION OF MANIFESTATION OF MENOPAUSAL SYMPTOMS (VERSIONS) | 2016 |
|
RU2611370C1 |
